Skip to main content
Erschienen in: HNO 3/2012

01.03.2012 | Leitthema

Diagnostik und Therapie atypischer Refluxsymptome bei fehlendem PPI-Ansprechen

verfasst von: PD Dr. M. Bajbouj

Erschienen in: HNO | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die gastroösophageale Refluxkrankheit (GERD) ist eine häufige chronische Krankheit mit 2 Formen: einerseits geprägt durch typische Symptome wie Sodbrennen und saures Aufstoßen; andererseits vornehmlich durch atypische Symptome wie z. B. chronischer Husten, Heiserkeit, Halsschmerzen, Globussensationen im Hals, Zungenbrennen, rezidivierende Sinusitiden, Asthma bronchiale, dentale Erosionen, retrosternale Schmerzen oder Räusperzwang durch Schleimproduktion. Zur Standardtherapie gehört eine medikamentöse Säuresuppression durch Protonenpumpenhemmer. Viele Patienten, insbesondere die mit atypischen Beschwerden, sprechen jedoch nicht adäquat auf die Therapie an. Erst nach sicherer Identifikation der GERD-Patienten durch eine valide Diagnostik kann eine modifizierte pharmakologische oder interventionelle Therapie individualisiert werden. Können atypische GERD-Symptome nicht objektiviert werden, liegt eher keine GERD vor. Andere Ursachen der Symptome müssen dann in Erwägung gezogen und behandelt werden.
Literatur
1.
Zurück zum Zitat Altman KW, Waltonen JD, Hammer ND et al (2005) Proton pump (H +/K + -ATPase) expression in human laryngeal seromucinous glands. Otolaryngol Head Neck Surg 133(5):718–724PubMedCrossRef Altman KW, Waltonen JD, Hammer ND et al (2005) Proton pump (H +/K + -ATPase) expression in human laryngeal seromucinous glands. Otolaryngol Head Neck Surg 133(5):718–724PubMedCrossRef
2.
Zurück zum Zitat Agrawal A, Roberts J, Sharma N et al (2009) Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22:467–470PubMedCrossRef Agrawal A, Roberts J, Sharma N et al (2009) Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22:467–470PubMedCrossRef
3.
Zurück zum Zitat Akbayir N, Sökmen HM, Caliş AB et al (2005) Heterotopic gastric mucosa in the cervical esophagus: could this play a role in the pathogenesis of laryngopharyngeal reflux in a subgroup of patients with posterior laryngitis? Scand J Gastroenterol 40:1149–1156PubMedCrossRef Akbayir N, Sökmen HM, Caliş AB et al (2005) Heterotopic gastric mucosa in the cervical esophagus: could this play a role in the pathogenesis of laryngopharyngeal reflux in a subgroup of patients with posterior laryngitis? Scand J Gastroenterol 40:1149–1156PubMedCrossRef
4.
Zurück zum Zitat Babaei A, Bhargava V, Aalam S et al (2009) Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging. Aliment Pharmacol Ther 29:863–870PubMedCrossRef Babaei A, Bhargava V, Aalam S et al (2009) Effect of proton pump inhibition on the gastric volume: assessed by magnetic resonance imaging. Aliment Pharmacol Ther 29:863–870PubMedCrossRef
5.
Zurück zum Zitat Bajbouj M, Becker V, Neuber M et al (2007) Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion 76:223–228PubMedCrossRef Bajbouj M, Becker V, Neuber M et al (2007) Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion 76:223–228PubMedCrossRef
6.
Zurück zum Zitat Bajbouj M, Becker V, Phillip V et al (2009) High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease–a prospective pH-metry/impedance-controlled study. Digestion 80:112–118PubMedCrossRef Bajbouj M, Becker V, Phillip V et al (2009) High-dose esomeprazole for treatment of symptomatic refractory gastroesophageal reflux disease–a prospective pH-metry/impedance-controlled study. Digestion 80:112–118PubMedCrossRef
7.
Zurück zum Zitat Bajbouj M, Becker V, Eckel F et al (2009) Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology 137:440–444PubMedCrossRef Bajbouj M, Becker V, Eckel F et al (2009) Argon plasma coagulation of cervical heterotopic gastric mucosa as an alternative treatment for globus sensations. Gastroenterology 137:440–444PubMedCrossRef
8.
Zurück zum Zitat Boeckxstaens GE (2008) Reflux inhibitors: a new approach for GERD? Curr Opin Pharmacol 8:685–689PubMedCrossRef Boeckxstaens GE (2008) Reflux inhibitors: a new approach for GERD? Curr Opin Pharmacol 8:685–689PubMedCrossRef
9.
Zurück zum Zitat Boeckxstaens GE, Beaumont H, Hatlebakk JG et al (2011) A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Gut: (in press) Boeckxstaens GE, Beaumont H, Hatlebakk JG et al (2011) A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial. Gut: (in press)
10.
Zurück zum Zitat Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798–1810PubMedCrossRef Chiba N, De Gara CJ, Wilkinson JM, Hunt RH (1997) Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 112:1798–1810PubMedCrossRef
11.
Zurück zum Zitat Fass R (2009) Proton pump inhibitor failure–what are the therapeutic options? Am J Gastroenterol 104:33–38CrossRef Fass R (2009) Proton pump inhibitor failure–what are the therapeutic options? Am J Gastroenterol 104:33–38CrossRef
12.
Zurück zum Zitat Friedman M, Maley A, Kelley K et al (2011) Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution. Otolaryngol Head Neck Surg 144(4):558–562PubMedCrossRef Friedman M, Maley A, Kelley K et al (2011) Impact of pH monitoring on laryngopharyngeal reflux treatment: improved compliance and symptom resolution. Otolaryngol Head Neck Surg 144(4):558–562PubMedCrossRef
13.
Zurück zum Zitat Gasiorowska A, Fass R (2008) The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 42:867–874PubMedCrossRef Gasiorowska A, Fass R (2008) The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 42:867–874PubMedCrossRef
14.
Zurück zum Zitat Hicks DM, Ours TM, Abelson TI et al (2002) The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 16:564–579PubMedCrossRef Hicks DM, Ours TM, Abelson TI et al (2002) The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 16:564–579PubMedCrossRef
15.
Zurück zum Zitat Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) Technical review on the management of gastroesophageal reflux disease. Gastroenterology 135:1392–1413PubMedCrossRef Kahrilas PJ, Shaheen NJ, Vaezi MF (2008) Technical review on the management of gastroesophageal reflux disease. Gastroenterology 135:1392–1413PubMedCrossRef
16.
Zurück zum Zitat Koek GH, Sifrim D, Lerut T et al (2003) Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52:1397–402PubMedCrossRef Koek GH, Sifrim D, Lerut T et al (2003) Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 52:1397–402PubMedCrossRef
17.
Zurück zum Zitat Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127:32–35PubMedCrossRef Koufman JA, Aviv JE, Casiano RR, Shaw GY (2002) Laryngopharyngeal reflux: position statement of the committee on speech, voice, and swallowing disorders of the American Academy of Otolaryngology-Head and Neck Surgery. Otolaryngol Head Neck Surg 127:32–35PubMedCrossRef
18.
Zurück zum Zitat Louis E, Jorissen P, Bastens B et al (2006) Atypical symptoms of GORD in Belgium: epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month. Acta Gastroenterol Belg 69:203–208PubMed Louis E, Jorissen P, Bastens B et al (2006) Atypical symptoms of GORD in Belgium: epidemiological features, current management and open label treatment with 40 mg esomeprazole for one month. Acta Gastroenterol Belg 69:203–208PubMed
19.
20.
Zurück zum Zitat Meining A, Bajbouj M (2006a) Endoscopic anti reflux treatment–unhappy ending or start of a new era? Z Gastroenterol 44:943–944PubMedCrossRef Meining A, Bajbouj M (2006a) Endoscopic anti reflux treatment–unhappy ending or start of a new era? Z Gastroenterol 44:943–944PubMedCrossRef
21.
Zurück zum Zitat Meining A, Bajbouj M, Preeg M et al (2006b) Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 38:566–570PubMedCrossRef Meining A, Bajbouj M, Preeg M et al (2006b) Argon plasma ablation of gastric inlet patches in the cervical esophagus may alleviate globus sensation: a pilot trial. Endoscopy 38:566–570PubMedCrossRef
22.
Zurück zum Zitat Poyrazoglu OK, Bahcecioglu IH, Dagli AF et al (2009) Heterotopic gastric mucosa (inlet patch): endoscopic prevalence, histopathological, demographical and clinical characteristics. Int J Clin Pract 63:287–291PubMedCrossRef Poyrazoglu OK, Bahcecioglu IH, Dagli AF et al (2009) Heterotopic gastric mucosa (inlet patch): endoscopic prevalence, histopathological, demographical and clinical characteristics. Int J Clin Pract 63:287–291PubMedCrossRef
23.
Zurück zum Zitat Reichel O, Issing WJ (2008) Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux. J Laryngol Otol 122:485–489PubMedCrossRef Reichel O, Issing WJ (2008) Impact of different pH thresholds for 24-hour dual probe pH monitoring in patients with suspected laryngopharyngeal reflux. J Laryngol Otol 122:485–489PubMedCrossRef
24.
Zurück zum Zitat Rosanowski F, Rabenstein T, Hahn EG, Eysholdt U (2001) Reflux-associated diseases of the otorhinolaryngology tract. Laryngorhinootologie 80(8):487–496PubMedCrossRef Rosanowski F, Rabenstein T, Hahn EG, Eysholdt U (2001) Reflux-associated diseases of the otorhinolaryngology tract. Laryngorhinootologie 80(8):487–496PubMedCrossRef
25.
Zurück zum Zitat Sifrim D, Silny J, Holloway RH, Janssens JJ (1999) Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 44:47–54PubMedCrossRef Sifrim D, Silny J, Holloway RH, Janssens JJ (1999) Patterns of gas and liquid reflux during transient lower oesophageal sphincter relaxation: a study using intraluminal electrical impedance. Gut 44:47–54PubMedCrossRef
26.
Zurück zum Zitat Steward DL, Wilson KM, Kelly DH et al (2004) Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131:342–350PubMedCrossRef Steward DL, Wilson KM, Kelly DH et al (2004) Proton pump inhibitor therapy for chronic laryngo-pharyngitis: a randomized placebo-control trial. Otolaryngol Head Neck Surg 131:342–350PubMedCrossRef
27.
Zurück zum Zitat Sun G, Muddana S, Slaughter JC et al (2009) A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope 119:1639–1643PubMedCrossRef Sun G, Muddana S, Slaughter JC et al (2009) A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope 119:1639–1643PubMedCrossRef
28.
Zurück zum Zitat Ulualp SO, Toohill RJ, Hoffmann R, Shaker R (1999) Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 13:197–202PubMedCrossRef Ulualp SO, Toohill RJ, Hoffmann R, Shaker R (1999) Possible relationship of gastroesophagopharyngeal acid reflux with pathogenesis of chronic sinusitis. Am J Rhinol 13:197–202PubMedCrossRef
29.
Zurück zum Zitat Vaezi MF, Richter JE, Stasney CR et al (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116:254–260PubMedCrossRef Vaezi MF, Richter JE, Stasney CR et al (2006) Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope 116:254–260PubMedCrossRef
30.
Zurück zum Zitat Vakil N, Zanten SV van, Kahrilas P et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920PubMedCrossRef Vakil N, Zanten SV van, Kahrilas P et al (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101:1900–1920PubMedCrossRef
Metadaten
Titel
Diagnostik und Therapie atypischer Refluxsymptome bei fehlendem PPI-Ansprechen
verfasst von
PD Dr. M. Bajbouj
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
HNO / Ausgabe 3/2012
Print ISSN: 0017-6192
Elektronische ISSN: 1433-0458
DOI
https://doi.org/10.1007/s00106-011-2430-9

Weitere Artikel der Ausgabe 3/2012

HNO 3/2012 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.